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Expanding the Roles of Antimicrobial 
Peptides in Skin: Alarming and 
Arming Keratinocytes
Jürgen Schauber1 and Richard L. Gallo1
Antimicrobial peptides are gene-encoded molecules first discovered for their 
microbicidal properties but recently shown to have pro- or anti-inflammatory 
functions. Their role as immune regulators is being expanded with evidence that 
some antimicrobial peptides stimulate keratinocyte migration, proliferation and 
cytokine or chemokine production. Poorly named, antimicrobial peptides are 
multifunctional pillars around which the innate and adaptive immune response 
has evolved.
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Antimicrobial peptides are endogenous 
antibiotics expressed in skin
The skin relies on innate defense mech-
anisms for rapid recognition of and 
protection against microbes. All epithe-
lial structures provide both a constitu-
tive physical and chemical barrier to 
infection and can respond with a tis-
sue-specific program against relevant 
local pathogens or injury. The release 
of antimicrobial peptides (AMPs) is 
an essential element of this process 
(Bardan et al., 2004). Originally iden-
tified through their direct antimicro-
bial function, there is more and more 
evidence that AMPs play an important 
additional role in orchestrating the 
adaptive immune response. Two main 
groups of AMPs in skin are the β-defen-
sins and the cathelicidins (Bardan et 
al., 2004). Defensins are a family of 
small AMPs, which, primarily on the 
basis of disulfide connectivity of cys-
teine residues, are classified into three 
subfamilies (α, β, and θ) (Zaiou and 
Gallo, 2002). In skin, only β-defensins 
are appreciably expressed (Schroder 
and Harder, 2006). Cathelicidins are a 
family of AMPs with an N-terminal pro-
sequence of approximately 100 amino 
acid residues known as the “cathelin” 
domain, and a C-terminal antimicro-
bial domain (Zaiou et al., 2003). The 
cathelin domain has functions as a pro-
tease inhibitor and acts to inhibit the 
growth of certain bacteria (Zaiou et al., 
2003). The C-terminal peptide domain 
is highly heterogeneous in terms of 
size and structure between organisms 
and exists as an α-helix, β-hairpin with 
one or two intrachain disulfide bonds, 
or extended polyproline-type folding, 
depending on the species (Zaiou and 
Gallo, 2002). Humans have a single 
cathelicidin gene, which encodes the 
mature antimicrobial peptide LL-37 and 
its precursor hCAP18 (Gudmundsson 
et al., 1996). Human cathelicidin can 
be enzymatically processed to release 
peptides other than LL-37 from the C 
terminus. In sweat, additional peptides 
have been found: KR-20 (a 20-amino 
acid derivative), RK-31, and KS-30 
(Murakami et al., 2004). Although their 
regulatory pathways are different, β-
defensins and cathelicidins are rapidly 
released at high local concentrations 
when needed in response to infection 
or epidermal injury (Dorschner et al., 
2001; Sorensen et al., 2006). Among 
the AMPs, only cathelicidins have been 
conclusively demonstrated to protect 
against skin infections (Howell et al., 
2006; Nizet et al., 2001), but at least a 
dozen additional peptides in the skin 
have been described to have antimi-
crobial properties (Braff and Gallo, 
2006), joining other molecules such as 
enzymes, free fatty acids, and reactive 
oxygen species as the innate chemical 
cutaneous antimicrobial shield.
Antimicrobial peptides are “alarmins” of 
the adaptive immune system
Recently, several studies have identi-
fied additional functions of the AMPs 
to complement their role as native anti-
biotics. Defensins and cathelicidins at 
nanomolar concentrations are chemo-
tactic for distinct sub-populations of 
leukocytes as well as some non-leuko-
cytes. Human β-defensins (hBDs) 1–3 
are chemotactic for memory T cells and 
immature dendritic cells. hBD2 attracts 
mast cells and activated neutrophils, 
whereas hBD3–4 is also chemotactic for 
monocytes/macrophages (Oppenheim 
and Yang, 2005). Cathelicidins are 
chemotactic for neutrophils, mono-
cytes/macrophages, and CD4 T lym-
phocytes (Agerberth et al., 2000). On 
the basis of these unique activities, 
the term “alarmins” has been pro-
posed to summarize the multiple func-
tions of AMPs as activators of adaptive 
immune responses (Oppenheim and 
Yang, 2005). Interestingly, pretreatment 
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of target cells with pertussis toxin sup-
presses the chemotactic effect of AMPs, 
suggesting that AMPs act through acti-
vation of G protein-coupled receptors 
(Braff et al., 2005).
In their role as “alarmins,” antimicrobial 
peptides activate human keratinocytes
In this issue of the Journal of 
Investigative Dermatology, Niyonsaba 
et al. (2007) characterize the “alarmin” 
effect of β-defensins and cathelicidin 
LL-37 on human keratinocytes. They 
find that stimulation of keratinocytes 
with AMPs at concentrations that do 
not exert antimicrobial activity — but 
are likely to be present at sites of infec-
tion and inflammation — induces the 
release of multiple chemokines and 
cytokines (Figure 1). As in leukocytes, 
this “alarming” effect of the AMPs is 
signaled through G protein-coupled 
receptors. Furthermore, β-defensins 
and cathelicidin LL-37 induce kera-
tinocyte proliferation and migration, 
thus underscoring the importance of 
released AMPs in wound repair. Their 
positive effect on cell proliferation 
involves activation of EGFR and down-
stream activation of STAT1 and STAT3. 
These data complement earlier studies 
showing that AMP stimulation leads to 
activation of several signaling pathways 
and cell responses (Figure 1) (Braff et 
al., 2005; Niyonsaba et al., 2005).
Interestingly, although structurally 
very different, β-defensins and cat-
helicidin show similar effects. Even 
more interestingly, hBD1 — structur-
ally closer to hBD2 and hBD3 — has 
no effect on cytokine release and cell 
proliferation, whereas LL-37 — struc-
turally unrelated to the β-defensins 
— is a strong inducer of a similar 
cell response. The question arises of 
whether the observed effects are spe-
cific for the distinct peptides or the 
result of an unspecific activation signal 
(such as induced intracellular calcium 
release, also observed in the study by 
Niyonsaba et al. (2007)). This could 
then trigger the subsequent activation 
of cytokine release. Other studies have 
suggested that cellular stresses alter 
the cell surface and conformation of 
cell surface receptors, thereby activat-
ing intracellular signaling pathways 
(Rosen and Greenberg, 1996; Rosette 
and Karin, 1996). In a similar man-
ner, β-defensins and cathelicidin may 
directly interact with the plasma mem-
brane to cause conformational changes 
that indirectly activate surface receptor 
domains linked to intracellular signal-
ing events (Di Nardo and Gallo, 2007).
The mechanisms by which G pro-
tein-coupled receptors and cell sur-
face receptor activation interact are 
not completely understood. However, 
there is evidence that these pathways 
may run parallel and fulfill different 
functions (Downward, 2003; Rubio et 
al., 2003). Therefore, AMP-mediated 
activation of keratinocyte transmem-
brane receptors, including both G 
protein-coupled receptors and EGFR, 
should be further explored to under-
stand the mechanism by which AMPs 
influence downstream production of 
immunostimulatory molecules.
The diverse functions of AMPs in 
human immunity are consistent with 
their early appearance in evolution, 
probably providing the protective foun-
dation from which the slow-respond-
ing but often more effective adaptive 
immune response could develop. The 
study by Niyonsaba et al. (2007) adds 
to the growing evidence that AMPs 
produced and secreted in the skin 
have more than one role in the com-
plex innate immune response. Their 
data raise an important issue: although 
much of the interest and research on 
AMPs has been linked to their func-
tion as antibiotics, they exert addi-
tional activities on the inflammatory 
and wound repair process. Functional 
paradigms need to be reworked, and 
safety carefully considered, before con-
templation of the therapeutic options 
for AMPs as immunomodulators or 
enhancers of the repair process.
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Figure 1. Schematic model of antimicrobial peptide-induced cytokine and chemokine release from 
human keratinocytes. Epidermal keratinocytes stimulated with either β-defensins or cathelicidins 
release an array of cytokines through stimulation of G protein-coupled receptors. Induction of IL-18 
by antimicrobial peptides (AMPs) has also been shown to be signaled through MEK-ERK (Niyonsaba 
et al., 2005). In addition, AMPs induce keratinocyte proliferation and migration, which involves EGFR 
signaling and STAT activation.
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Complicated Hyaluronan Patterns in 
Skin: Enlightenment by UVB?
Robert Stern1
Hyaluronan has a complex metabolism with rapid turnover in skin, with wide 
differences occurring in dermal and epidermal compartments. Analyses of 
acute UVB irradiation of skin, as documented in cultured human fibroblast 
and immortalized keratinocyte cell culture media, confirm that no simple pat-
terns are present. A systematic approach has been initiated in the studies by 
Averbeck et al.
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gene-encoded mammalian antibiotics. J Mol 
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and protease inhibitory functions of the human 
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UVB represents only 0.5% of the 
sunlight reaching the Earth’s surface 
but is far more skin-penetrating than 
any other components of sunlight. It 
also accounts for much of the acute 
and chronic sun-related damage to 
skin. Hyaluronan (HA) is a non-sul-
phated, straight-chain glycosamino-
glycan polymer of the extracellular 
matrix. Half of total-body HA is locat-
ed within skin, where it is responsible 
for skin hydration. It occurs at much-
increased levels in response to injury 
and repair. Its turnover rate is very 
rapid, with a 1/2 life of 2–5 minutes in 
the circulation (Fraser et al., 1981) and 
1–2 days in the epidermis (Reed et al., 
1988). The turnover rate in the dermis, 
however, where most skin HA occurs, 
is not clear. Nor is dermal metabolism 
of this important polymer understood. 
HA metabolism in skin is even more 
complex than formerly assumed.
Histological and biochemical 
analyses of HA metabolism follow-
ing chronic UVB exposure in mice 
have been contradictory. Some report 
an increase, whereas others report no 
change. Vastly different mechanisms 
for regulation of HA deposition occur 
within the two skin compartments, 
with separate profiles of growth factors 
and cytokines affecting the enzymes 
that modulate deposition.
To initiate systematic examination 
of HA metabolism, a study of short-
term UVB irradiation was undertaken. 
Cultured human dermal fibroblasts and 
epidermal keratinocytes were used as 
paradigms of their respective compart-
ments. A differential response to short 
irradiation was observed, involving 
complex temporal and spatial patterns. 
Net HA deposition is the result of an 
equilibrium between HA synthesis by 
the three HA synthases and catabolism 
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